Shorter Oral Regimens Measure Up to Standard Ones for Rifampin-Resistant TB

(MedPage Today) -- In the search for shorter, effective, and safe regimens to treat fluoroquinolone-susceptible, rifampin-resistant tuberculosis (TB), three 9-month regimens incorporating newer and repurposed drugs proved on par with standard 18...